Skip to main content
Caplight Logo









One Zyme

One Zyme

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://www.onezyme.ai/

Last Round

VC Round

Jan 1, 2025

Company Overview

One Zyme is a biotechnology company that provides an AI-powered intelligence platform for pharmaceutical business development, competitive intelligence, and R&D strategy.

Sector

Healthcare & Life Sciences

Verticals

Business Intelligence, Biotechnology, Healthcare Analytics, Workflow Automation, Drug Discovery

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

biopharma intelligenceAI research agentsbiotech intelligencecompetitive intelligencedrug discoveryworkflow automationknowledge graphasset discoverylicensing diligencehealthcare analyticsai agentai copilotbiotech aipharma techsaas

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

One Zyme Comparables

Compare One Zyme with similar companies based on industry and business-model similarity.

One Zyme comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Maven Bio
94%
Prudentia Sciences
89%
Floatz
88%

One Zyme Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJan 1, 2025

Key People

Founding team and executive leadership

Sachin Raj

Co-Founder and CTO

Founding Team

Aaron Michel

Co-Founder And CEO

Founding Team

One Zyme Investors

Notable investors and investment history

One Zyme investors
InvestorRounds
Service Provider CapitalVC Round
Invariantes FundVC Round
Esplanade VenturesVC Round
Newfund CapitalVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 3, 2026

    Monthly visitors increased 41% MoM.

  • Jan 1, 2025

    Fundraise included Esplanade Ventures, Invariantes Fund, Newfund Capital, and Service Provider Capital.

One Zyme Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

One Zyme Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about One Zyme's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range6
Year Founded2025
Last FundingJan 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?